• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Tea Party gets chance to shape future of health care regulation with key committee spots

Tea Party gets chance to shape future of health care regulation with key committee spots

January 21, 2011 By MassDevice staff

Healthcare reform

The Tea Party will get a seat at the health care regulation table after a key congressional subcommittee on health was named on Thursday.

The 27-member health sub-committee of the House Energy and Commerce Committee of the 112th Congress has broad oversight over several regulatory bodies, including the Food & Drug Administration and the Centers for Medicare and Medicaid Services.

The GOP-controlled committee is chaired by Rep. Joseph Pitts (R-Pa.), and Rep. Michael Burgess (R-Texas) was named vice chair of the committee. The Texas republican is also a member of the Tea Party caucus in the House along with fellow Texan Rep. Joe Barton (R-Texas) and Phil Gingrey (R-Ga.), who were also named to the committee.

During the recent midterm elections, republicans took control of the House on the backs of momentum drummed up by members of the Tea Party who championed smaller government, opposition to the healthcare reform law and less regulation on American businesses. Now they will get a chance to shape the way health care is regulated.

The committee, which will debate a whole host of healthcare-related issues, could also be instrumental in the upcoming re-authorization of the FDA’s Medical Device User Fee Act, which is slated for 2012.

The full list of congressional leaders named to committee are:

Chairman Joseph Pitts (R-Pa.)
Vice Chairman Michael Burgess (R-Texas)
Rep. Ed Whitfield (R-Ky.)
Rep. John Shimkus (R-Ill.)
Rep. Mike Rogers (R-Mich.)
Rep. Sue Myrick (R-N.C.)
Rep. Tim Murphy (R-Pa.)
Rep. Marsha Blackburn (R-Tenn.)
Rep. Phil Gingrey (R-Ga.)
Rep. Bob Latta (R-Ohio)
Rep. Cathy McMorris Rodgers (R-Wash.)
Rep. Leonard Lance (R-N.J.)
Rep. Bill Cassidy (R-La.)
Rep. Brett Guthrie (R-Ky.)
Rep. Joe Barton (R-Texas, ex officio)
Rep. Fred Upton (R-Mich., ex officio)
Rep. Frank Pallone (D-N.J., ranking member)
Rep. John Dingell (D-Mich.)
Rep. Edolphus Towns (D-N.Y.)
Rep. Eliot Engel (D-N.Y.)
Rep. Lois Capps (D-Calif.)
Rep. Jan Schakowsky (D-Ill.)
Rep. Charles Gonzalez (D-Texas)
Rep. Tammy Baldwin (D-Wis.)
Rep. Mike Ross (D-Ark.)
Rep. Anthony Weiner (D-N.Y.)
Rep. Henry Waxman (D-Calif., ex officio)

Filed Under: Business/Financial News, News Well Tagged With: Gift Bans

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy